Clostridium difficile, commonly known as C difficile or C-diff, is rapidly gaining ground as the second-most destructive source of hospital-acquired infection after methicillin-resistant Staphylococcus aureus. Like MRSA, C-diff is also appearing more frequently in the community in patients with no recent history of hospitalization.
Trending:
Move over, MRSA, C-diff is the new tough bug